Antioxidants as a Bio-shield Against Radiological Weapons
There are two types of radiological weapon, “dirty bomb,” and nuclear weapon (atom bomb). A dirty bomb can be made from one or more commercially available radioactive isotopes and it can be detonated using a conventional explosive, whereas an atom bomb consists of fissionable element, and it requires complex procedures for detonation. Explosion of a radiological weapon can cause a few injuries to mass casualties, depending upon the type of radiological weapon, and can increase the chronic health risks among survivors. Bio-Shield refers to chemicals or biologics that can prevent or mitigate radiation injury when administered before and/or after irradiation. During past decades, several radiation preventive and mitigating agents been identified. They can be grouped into following categories: (a) chemicals not approved by the FDA, (b) drugs approved by the FDA for other conditions, (c) certain biologics approved by the FDA, and (d) antioxidants and herbs not requiring FDA approval. An effective bio-shield that can be recommended to humans must satisfy the following three criteria: (1) chemicals or biologics should prevent and/or mitigate radiation damage in the laboratory experiments when administered before and/or after irradiation; (2) they should show at least some evidence that they can prevent or mitigate radiation damage in humans; and (3) they at radiation preventive or radiation mitigating doses must be safe in human when administered on a short- or long-term basis. Published data show that most radiation preventing and mitigating chemicals, drugs or herbs satisfy only the first criterion of an effective bio-shield, whereas antioxidants satisfy all three.
KeywordsRadiation Injury Atom Bomb Ethyl Pyruvate Acute Radiation Sickness Dirty Bomb
Conflict of Interest
The author is an employee of Premier Micronutrient Corporation, and has a financial interest.
- 11.Cui L, Fu Q, Kumar KS, Hauer-Jensen M (2010) γ-Tocotrienol and/or pentoxifylline attenuates DNA and lipid oxidative damage in mice intestine after total body irradiation. In: 56th annual meeting of Radiation Research Society, Maui, 25–29 Sept 2010, p 55aGoogle Scholar
- 14.Ehrlich JS, Brand M, Uder M et al (2011) Effect of proprietary combination of antioxidants/glutathione-elevating agents on X-ray induced DNA double-strand breaks. Presented at the annual meeting of Society of Cardiovascular Computed Tomography, Denver, Colorado, USA 2011Google Scholar
- 28.Kulkarni SS, Ghosh S. Hieber K et al (2010) Radioprotective efficacy of γ-tocotrienol and pentoxifylline combination in murine model. In: 56th annual meeting of Radiation Research Society, Maui, 25–29 Sept 2012, p 58aGoogle Scholar
- 41.Prasad KN (1995) Handbook of radiobiology. CRC Press, Boca RatonGoogle Scholar
- 42.Prasad KN (2012) Health risks of low doses of ionizing radiation. In: Radiation injury prevention and mitigation in humans. CRC Press, Boca RatonGoogle Scholar
- 43.Prasad KN (2012) Prevention and mitigation of acute radiation sickness (ARS) produced by high doses of ionizing radiation. In: Radiation injury prevention and mitigation in humans. CRC Press, Boca RatonGoogle Scholar
- 48.Ryan JL, Heckler CE, Williams J et al (2010) Curcumin treatment and prediction of radiation dermatitis in breast cancer patients. In: 56th annual meeting of Radiation Research Society, Maui, 25–29 Sept 2010, p 178aGoogle Scholar
- 58.Xiao M, Li XH, Fu D et al (2010) Radioprotective and therapeutic effects of δ-tocotrienol in mouse bone marrow hematopoietic tissue (in vivo study). In: 56th annual meeting of Radiation Research Society, Maui, 25–29 Sept 2010, p 129aGoogle Scholar